🇺🇸 FDA
Pipeline program

Paclitaxel

R120537

Phase 2 small_molecule active

Quick answer

Paclitaxel for Carcinosarcoma is a Phase 2 program (small_molecule) at Cardiff Oncology with 1 ClinicalTrials.gov record(s).

Program details

Company
Cardiff Oncology
Indication
Carcinosarcoma
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials